Fauci: long Covid-19 trial endpoints ‘absolutely have to be standardised’
Long Covid-19 affects as many as one in five people who previously had an acute Covid-19 infection. But a constellation of distinct symptoms—ranging from breathing problems to brain fog—makes designing clinical trials a steep challenge....